Fibrosing colonopathy in cystic fibrosis

Archives of Disease in Childhood

Volumn 74, Issue 3 SUPPL., 1996, Pages 464-468

  Smyth, Rosalind L ^a  

^a Children's Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREON 25; KREON; NUTRIZYME; PANCREAS ENZYME; PANCRELIPASE; UNCLASSIFIED DRUG;

CLINICAL FEATURE; COLON OBSTRUCTION; COLONOSCOPY; CYSTIC FIBROSIS; DRUG USE; HISTOLOGY; HUMAN; MALABSORPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030008416     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.74.5.464     Document Type: Short Survey

References (24)

1. Smyth RL, Van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 343: 85-6.
2. Oades PJ, Bush A, Ong PS, Brereton RJ. High strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet 1994; 343: 109.
3. Campbell CA, Forrest J, Musgrove C. High strength pancreatic enzyme supplements and large bowel stricture in cystic fibrosis. Lancet 1994; 343: 109-10.
4. Pettei MJ, Leonidas JC, Levine JJ, Gorvoy JD. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy. J Pediatr 1994; 125: 587-9.
5. Knabe N, Zak M, Hansen A, et al. Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 363: 1230.
6. Lloyd-Still JD. Crohn's disease and cystic fibrosis. Dig Dis Sci 1994; 39: 880-5.
7. Zerin JM, Kuhn-Fulton J, White SJ, et al. Colonic strictures in children with cystic fibrosis. Radiology 1995; 194: 223-6.
8. Rosenstein BJ, Langbaum TS. Incidence of distal intestinal obstruction syndrome in cystic fibrosis. J Pediatr Gastroenterol Nutr 1983; 2: 299-301.
9. MacSweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A. Relation of thickening of colon wall to pancreatic enzyme treatment in cystic fibrosis. Lancet 1995; 345: 752-6.
10. Taylor CJ. Commentary: colonic strictures in cystic fibrosis. Lancet 1994; 343: 615-6.
11. Carty H. Abdominal radiology in cystic fibrosis. J R Soc Med 1994; 88 (suppl 25): 18-23.
12. Smyth RL, Carry H, Heaf DP. Colonic strictures in cystic fibrosis [Letter]. Arch Dis Child 1995; 73: 184.
13. King S. Radiological features of fibrosing colonopathy [Letter]. Lancet 1995; 346: 1496.
14. Smyth RL, Ashby D, O'Hea U, et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346: 1247-51.
15. Committee on Safety of Medicines, Medicines Control Agency. Update: bowel strictures and high-potency pancreatins. Current Problems in Pharmacovigilance 1994; 20: 13.
16. Lebenthal E. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: 'More is not necessarily better' [Editorial]. J Pediatr Gastroenterol Nutr 1994; 18: 423-5.
17. Lloyd-Still JD. Cystic fibrosis and colonic strictures. A new 'iatrogenic' disease. J Clin Gastroenterol 1993; 21: 2-5.
18. Treon JF, Sigmon H, Wright H, Kitzmiller KV. The toxicity of methyl and ethyl acrylate. Journal of Industrial Hygiene and Toxicology 1949; 31: 317-26.
19. Ghanayem BI, Maronpot RR, Matthews HB. Ethyl acrylate-induced gastric toxicity. I Effect of single and repetitive dosing. Taxicol Appl Pharmacol 1985; 80: 323-35.
20. Van Velzen D. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995; 346: 499-500.
21. Jones R, Franklin K, Spicer R, Berry J. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995; 346: 499.
22. Croft NM, Marshall TG, Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet 1995; 346: 1265-7.
23. Committee on Safety of Medicines, Medicines Control Agency. Fibrosing colonopathy associated with pancreatic enzymes. Current Problems in Pharmacovigilance 1995; 21: 11.
24. Borowitz DS, Grand RJ, Durie P and the Consensus Committee. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr 1995; 127: 681-4.